Looks like a comprehensive categorization of the available (and soon to be available) solutions, based on their method of application. Sanvita is classed as MI-GM (minimumally invasive glucose monitor), but unfortunately, not a lot of extra information on Sanvita's solution is supplied in the tables (man, they seem to run a tight ship!). Maybe you'll be able to spot something useful.
The competition looks intense, and includes Biolinq in the same category (MI-GM) that we have a bit more infomration about - Silicon sensor chip of a few mm in width and length, with microneedles for sub-cutaneous access. We know that Biolinq has been recruitng for engineers to interact with their foundry (unknown who they are). Still behind in the commercialisation journey though I think, thank goodness.
The Sanvita solution doesn't look to be silicon-based, from the patent, it is made on a glass substrate, with multiple layers of deposition - another of Sensera's capabilities.
These two figures from the Sanvita patent give a feel for the solution - both the "inserter" (top left in first figure) and the oval sensor housing that stays on the skin (second figure).
SE1 Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
